Global Normothermic Machine Perfusion System Market Strategic Research Report

Scope of the Report

The global Normothermic Machine Perfusion System market size is predicted to grow from US$ 1,976 million in 2025 to US$ 6,428 million in 2032; it is expected to grow at a CAGR of 18.4% from 2026 to 2032.

A normothermic machine perfusion system is an active ex vivo organ preservation and assessment platform used to maintain donor organs before transplantation. It combines pumps, an oxygenator, heating modules, pressure and flow sensors, an organ chamber, disposable circuits, and control software to deliver oxygenated or blood-based perfusate to organs such as the liver, kidney, heart, and lung at near-physiological temperature. The system is designed to reduce cold ischemic injury, extend preservation time, and support reassessment of marginal donor organs. Products are usually differentiated by closed-loop temperature control, pressure and flow management, real-time monitoring, sterile disposable circuits, clinical compliance, and transplant-center support; the comprehensive gross margin is about 58%.

Demand mainly comes from transplant centers, organ procurement organizations, in-hospital organ assessment platforms, and preclinical research institutions. The shortage of donor organs, rising use of marginal and DCD donors, and cross-regional transport needs are pushing transplant teams toward normothermic perfusion equipment that can maintain organ metabolism, monitor functional indicators, and create a more flexible surgical window.

Product development is focused on multi-organ compatibility, portability, sterile disposable circuits, automated control, data logging, and remote monitoring. The clinical market is led by a small group of companies with regulatory approvals, clinical evidence, and transplant-service networks, while research demand is served more by benchtop or modular systems for ex vivo liver, kidney, heart, and lung models, pharmacology, toxicology, and ischemia-reperfusion studies.

Regional opportunities are concentrated in large transplant centers in North America and Europe, while Asia Pacific demand is supported by transplant-volume growth, local-device substitution, and hospital infrastructure expansion. Entry barriers include clinical validation, regulatory clearance, tied disposable circuits, service response, and perfusion-protocol know-how; risks include high system cost, reimbursement differences, long operator training cycles, and uneven expansion across organ indications.

Report Scope

Key Questions Addressed in this Report

What is the 10-year outlook for the global Normothermic Machine Perfusion System market?

What factors are driving Normothermic Machine Perfusion System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Normothermic Machine Perfusion System market opportunities vary by end market size?

How does Normothermic Machine Perfusion System break out by Type, by Application?

This report presents a comprehensive overview of the global Normothermic Machine Perfusion System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Liver Perfusion Systems
• Kidney Perfusion Systems
• Heart Perfusion Systems
• Lung Perfusion Systems
• Multi-Organ Perfusion Systems

Segment by Deployment Format

• Portable Transport Systems
• Stationary Cart Systems
• Benchtop Research Systems
• Modular Custom Systems

Segment by Perfusate System

• Whole Blood-Based Perfusate Systems
• Packed Red Cell-Based Perfusate Systems
• Acellular Oxygenated Solution Systems
• Custom Research Perfusate Systems

Segment by Automation Level

• Fully Automated Closed-Loop Systems
• Semi-Automated Monitored Systems
• Manually Controlled Laboratory Systems
• Modular OEM Integration Systems

Segment by Application

• Liver Transplantation
• Kidney Transplantation
• Heart Transplantation
• Lung Transplantation and EVLP
• Organ Viability Assessment
• Preclinical and Translational Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Normothermic Machine Perfusion System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Liver Transplantation, Kidney Transplantation, Heart Transplantation evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact